Literature DB >> 8307150

Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules.

M Howell1, A Shirvan, Y Stern-Bach, S Steiner-Mordoch, J E Strasser, G E Dean, S Schuldiner.   

Abstract

Using oligonucleotide primers derived from the vesicular monoamine transporters sequences, a cDNA predicted to encode the bovine chromaffin granule amine transporter has been cloned (b-VMAT2). Surprisingly, its structure is more similar to the rat brain transporter (VMAT2), than to the rat adrenal counterpart (VMAT1). Unlike rat VMAT1, bovine VMAT2 appears to be expressed both in the adrenal medulla and the brain, as judged by Northern analysis. After modification/deletion of the seven amino acids at the N-terminus of the protein it was expressed in a functional form. The order of affinity of the bovine VMAT2 transporter to substrates is: serotonin > dopamine = norepinephrine > epinephrine. Also, the recombinant bovine adrenal transporter is highly sensitive to tetrabenazine, in sharp contrast to the rat adrenal transporter. The findings indicate, therefore, a clear species variation in which structure and function of the bovine adrenal transporter resemble the rat brain protein, while its tissue distribution is distinct from both types of rat proteins. In addition, the predicted protein sequence is identical to the experimentally determined N-terminus sequence of the purified vesicular amine transporter [Stern-Bach et al. (1992) Proc. Natl. Acad. Sci. USA 89, 9730-9733].

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307150     DOI: 10.1016/0014-5793(94)80108-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Membrane composition of adrenergic large and small dense cored vesicles and of synaptic vesicles: consequences for their biogenesis.

Authors:  H Winkler
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

Review 2.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

Review 3.  Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.

Authors:  Peter A Crooks; Guangrong Zheng; Ashish P Vartak; John P Culver; Fang Zheng; David B Horton; Linda P Dwoskin
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Expression and regulation of a vesicular monoamine transporter in rat stomach: a putative histamine transporter.

Authors:  R Dimaline; J Struthers
Journal:  J Physiol       Date:  1996-01-01       Impact factor: 5.182

5.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

6.  Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.

Authors:  J D Erickson; M K Schafer; T I Bonner; L E Eiden; E Weihe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.

Authors:  F Watson; D G Deavall; J A Macro; R Kiernan; R Dimaline
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

8.  Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.

Authors:  Anthony Raffo; Kolbe Hancock; Teresa Polito; Yuli Xie; Gordon Andan; Piotr Witkowski; Mark Hardy; Pasquale Barba; Caterina Ferrara; Antonella Maffei; Matthew Freeby; Robin Goland; Rudolph L Leibel; Ian R Sweet; Paul E Harris
Journal:  J Endocrinol       Date:  2008-07       Impact factor: 4.286

9.  The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.

Authors:  J S Duerr; D L Frisby; J Gaskin; A Duke; K Asermely; D Huddleston; L E Eiden; J B Rand
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

10.  Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.

Authors:  M K-H Schäfer; N R Hartwig; N Kalmbach; M Klietz; M Anlauf; L E Eiden; E Weihe
Journal:  Diabetologia       Date:  2013-02-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.